Opioid Analgesic Reduction Study

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

1,815

Participants

Timeline

Start Date

January 4, 2021

Primary Completion Date

July 7, 2023

Study Completion Date

December 31, 2025

Conditions
Opioid Use
Interventions
DRUG

opioid-containing analgesic

hydrocodone/ acetaminophen combination product

DRUG

two over-the-counter analgesics

combination of over-the-counter analgesics (ibuprofen/acetaminophen)

Trial Locations (5)

14620

University of Rochester, Rochester

21201

University of Maryland, Baltimore

48109

University of Michigan, Ann Arbor

60612

University of Illinois at Chicago, Chicago

07101

Rutgers School of Dental Medicine, Newark

All Listed Sponsors
collaborator

National Institute of Dental and Craniofacial Research (NIDCR)

NIH

collaborator

University of Rochester

OTHER

collaborator

University of Maryland, Baltimore

OTHER

collaborator

University of Illinois at Chicago

OTHER

collaborator

University of Michigan

OTHER

lead

Rutgers, The State University of New Jersey

OTHER

NCT04452344 - Opioid Analgesic Reduction Study | Biotech Hunter | Biotech Hunter